Sabra Health Care REIT, Inc. (SBRA) 10-Year Financial Performance & Capital Metrics

SBRA • • REIT / Real Estate

Real EstateHealthcare REITsSenior housing and skilled nursing

AboutAs of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.Show more

Revenue $775M +10.2%
FFO $342M +15.5%
FFO/Share 1.40 +11.5%
FFO Payout 84.59% -10.5%
FFO per Share 1.40 +11.5%
NOI Margin 100% +47.7%
FFO Margin 44.18% +4.8%
ROE 5.58% +22.1%
ROA 2.88% +21.3%
Debt/Assets 22.88% -50.3%
Net Debt/EBITDA 3.48 -37.7%
Book Value/Share 11.55 -0.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓FFO growing 15.4% TTM
✓High NOI margin of 100.0%
✓Healthy dividend yield of 5.8%
✓Trading near 52-week high

✗Weaknesses

✗Weak 3Y average ROE of 3.5%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y12.48%

5Y5.29%

3Y7.43%

TTM10.15%

Profit (Net Income) CAGR

10Y6.93%

5Y2.32%

3Y-

TTM22.21%

EPS CAGR

10Y-

5Y-

3Y-

TTM0.45%

ROCE

10Y Avg5.2%

5Y Avg4.25%

3Y Avg4.61%

Latest-

Peer Comparison

Senior housing and skilled nursing

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OHIOmega Healthcare Investors, Inc.	13.47B	48.27	31.14	10.7%	50.19%	10.98%	5.56%	1.02
NHINational Health Investors, Inc.	4.06B	84.07	27.84	12.07%	380.47%	92.81%	5.83%
CTRECareTrust REIT, Inc.	9.05B	40.62	25.87	108.71%	80.64%	6.51%	4.35%
STRWStrawberry Fields REIT LLC	167.94M	12.80	22.46	17.29%	4.83%	11.22%	21.04%	8.04
LTCLTC Properties, Inc.	1.92B	39.68	15.75	25.26%	44.88%	10.15%	7.07%	0.55
SBRASabra Health Care REIT, Inc.	5.17B	20.55		10.15%	19.99%	5.48%	6.74%	0.45

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue+	260.53M	405.65M	623.41M	668.18M	598.57M	569.54M	624.81M	647.51M	703.24M	774.63M
Revenue Growth %	9.07%	55.7%	53.68%	7.18%	-10.42%	-4.85%	9.7%	3.63%	8.61%	10.15%
Property Operating Expenses	5.7M	17.86M	49.55M	109.71M	131.55M	141.2M	162.61M	195.25M	227.09M	0
Net Operating Income (NOI)+	-	-	-	-	-	-	-	-	-	-
NOI Margin %	-	-	-	-	-	-	-	-	-	-
Operating Expenses+	93.93M	163.4M	266.91M	30.89M	467.02M	217.59M	227.36M	230.56M	219.12M	53.71M
G&A Expenses	19.92M	32.4M	36.46M	30.89M	32.76M	34.67M	39.57M	47.47M	50.07M	53.71M
EBITDA+	253.85M	387.82M	613.14M	708.63M	416.29M	389.74M	422.62M	404.8M	426.65M	340.42M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization+	92.96M	163.43M	306.19M	181.04M	176.74M	178.99M	187.78M	183.09M	169.62M	187M
D&A / Revenue %	-	-	-	-	-	-	-	-	-	-
Operating Income+	160.89M	224.39M	306.95M	527.59M	0	210.75M	234.84M	221.71M	257.03M	0
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense+	64.87M	88.44M	147.11M	126.61M	100.42M	98.63M	105.47M	112.96M	115.27M	0
Interest Coverage	2.48x	2.54x	2.09x	4.17x	-	2.14x	2.23x	1.96x	2.23x	-
Non-Operating Income	27.01M	-14.93M	-122.92M	181.55M	-239.55M	223.53M	205.73M	92.99M	14.04M	0
Pretax Income+	70.2M	159.02M	282.13M	72.42M	139.13M	-111.41M	-76.36M	15.76M	127.72M	153.42M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	75.48M	651K	3.01M	3.4M	710K	1.84M	1.24M	2M	1M	-1.84M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	70.28M	158.38M	279.08M	69M	138.42M	-113.26M	-77.61M	13.76M	126.71M	155.26M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-11.51%	125.37%	76.21%	-75.28%	100.62%	-181.82%	31.48%	117.73%	821.14%	22.53%
Funds From Operations (FFO)+	-	-	-	-	-	-	-	-	-	-
FFO Margin %	-	-	-	-	-	-	-	-	-	-
FFO Growth %	14.56%	97.15%	81.87%	-57.28%	26.04%	-79.14%	67.61%	78.66%	50.54%	15.5%
FFO per Share+	-	-	-	-	-	-	-	-	-	-
FFO Payout Ratio %	-	-	-	-	-	-	-	-	-	-
EPS (Diluted)+	0.92	1.40	1.56	0.37	0.67	-0.52	-0.34	0.06	0.54	0.00
EPS Growth %	-17.12%	52.17%	11.43%	-76.28%	81.08%	-177.61%	34.62%	117.38%	813.71%	-100%
EPS (Basic)	0.92	1.40	1.57	0.37	0.67	-0.52	-0.34	0.06	0.54	0.00
Diluted Shares Outstanding	65.52M	105.84M	178.72M	188.13M	207.25M	219.07M	230.95M	232.79M	236.05M	244.5M

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets+	2.27B	7.03B	6.67B	6.07B	5.99B	5.97B	5.75B	5.39B	5.3B	5.49B
Asset Growth %	-8.86%	210.35%	-5.22%	-8.94%	-1.38%	-0.32%	-3.67%	-6.29%	-1.53%	3.58%
Real Estate & Other Assets+	-2.34B	-7.08B	-6.67B	-110.81M	-82.8M	5.5B	5.32B	4.98B	4.9B	0
PP&E (Net)	2.01B	5.99B	5.85B	9.3M	0	0	0	0	0	0
Investment Securities	1000K	1000K	1000K	0	0	1000K	1000K	1000K	1000K	0
Total Current Assets+	255.98M	870.73M	340.54M	0	0	253.99M	201.84M	180.53M	198.09M	182.83M
Cash & Equivalents	25.66M	518.63M	50.23M	49.14M	65.52M	112M	49.31M	41.28M	60.47M	71.54M
Receivables	0	1000K	1000K	0	0	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	68.82M	9.43M	-49.14M	-65.52M	3.89M	4.62M	5.43M	5.87M	0
Intangible Assets	26.25M	167.12M	131.1M	0	0	54.06M	40.13M	30.9M	27.46M	65.32M
Total Liabilities	1.25B	3.6B	3.41B	2.58B	2.58B	2.59B	2.69B	2.58B	2.56B	2.67B
Total Debt+	1.21B	3.39B	3.23B	2.48B	2.43B	2.44B	2.55B	2.45B	2.44B	1.26B
Net Debt	1.19B	2.88B	3.18B	2.43B	2.36B	2.33B	2.5B	2.41B	2.38B	1.19B
Long-Term Debt	1.21B	3.39B	3.23B	2.4B	2.35B	2.39B	2.31B	2.32B	2.31B	0
Short-Term Borrowings	4.13M	0	3.42M	3.57M	18.42M	0	196.98M	94.43M	106.55M	1.26B
Capital Lease Obligations	0	98.02M	83.73M	79.75M	57.73M	49.71M	42.24M	32.53M	26.85M	0
Total Current Liabilities+	39.64M	102.52M	94.83M	0	0	142.99M	339.24M	231.41M	224.45M	1.26B
Accounts Payable	39.64M	102.52M	94.83M	0	0	0	0	0	0	0
Deferred Revenue	1.25B	3.6B	3.41B	0	0	0	0	0	0	0
Other Liabilities	-644.48M	0	-1.29B	-2.48B	-2.41B	0	0	0	0	1.41B
Total Equity+	1.02B	3.44B	3.25B	3.49B	3.41B	3.38B	3.06B	2.8B	2.74B	2.82B
Equity Growth %	-3.63%	238.44%	-5.31%	7.18%	-2.27%	-0.87%	-9.56%	-8.31%	-2.19%	3.01%
Shareholders Equity	1.02B	3.43B	3.25B	3.49B	3.41B	3.38B	3.06B	2.8B	2.74B	2.82B
Minority Interest	35K	4.44M	4.33M	0	0	0	0	0	0	1.95M
Common Stock	653K	1.78M	1.78M	2.05M	2.11M	2.3M	2.31M	2.31M	2.38M	2.52M
Additional Paid-in Capital	1.21B	3.64B	3.51B	4.07B	4.16B	4.48B	4.49B	4.49B	4.59B	0
Retained Earnings	-192.2M	-217.24M	-271.6M	-573.28M	-716.2M	-1.1B	-1.45B	-1.72B	-1.87B	0
Preferred Stock	58K	58K	0	0	0	0	0	0	0	0
Return on Assets (ROA)	2.96%	3.41%	4.07%	1.08%	2.3%	-1.9%	-1.32%	0.25%	2.37%	2.88%
Return on Equity (ROE)	6.79%	7.11%	8.34%	2.05%	4.01%	-3.34%	-2.41%	0.47%	4.57%	5.58%
Debt / Assets	53.43%	48.27%	48.49%	40.89%	40.6%	40.96%	44.35%	45.42%	46.09%	22.88%
Debt / Equity	1.19x	0.99x	0.99x	0.71x	0.71x	0.72x	0.83x	0.87x	0.89x	0.45x
Net Debt / EBITDA	4.67x	7.42x	5.19x	3.43x	5.68x	5.98x	5.91x	5.94x	5.59x	3.48x
Book Value per Share	15.50	32.48	18.21	18.54	16.45	15.43	13.23	12.04	11.61	11.55

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	176.74M	133.49M	358.54M	372.48M	354.85M	356.39M	315.73M	300.57M	310.54M	348.61M
Operating CF Growth %	45.94%	-24.47%	168.6%	3.89%	-4.73%	0.43%	-11.41%	-4.8%	3.32%	12.26%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	70.2M	158.37M	279.12M	69.02M	138.42M	-113.26M	-77.61M	13.76M	126.71M	155.51M
Depreciation & Amortization	68.47M	112.97M	199.08M	181.55M	176.74M	178.99M	187.78M	183.09M	169.62M	187M
Stock-Based Compensation	7.5M	8.36M	7.65M	9.82M	7.91M	7.91M	7.45M	7.92M	8.99M	11.36M
Other Non-Cash Items	-17.78M	-22.86M	-36.31M	-22.16M	1.61M	32.2M	217.8M	98.55M	27.77M	-5.25M
Working Capital Changes	6.31M	-90.31M	-18.5M	-23.51M	-2.74M	22.7M	-19.69M	-2.73M	-22.55M	0
Cash from Investing+	142.36M	-240.07M	-258.49M	262.84M	-136.45M	-336.2M	-216.25M	103.13M	-109M	-377.96M
Acquisitions (Net)	-7.35M	77.86M	-354.46M	0	-16.65M	-7.77M	-142.91M	-5.24M	0	0
Purchase of Investments	-7.35M	-2.75M	-5.31M	-89.65M	-20.07M	-9.06M	-8.02M	-11.02M	0	0
Sale of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0	0	0
Other Investing	157.06M	15.19M	1.06M	347.42M	2.44M	-287.05M	-70.69M	119.39M	-109M	-377.96M
Cash from Financing+	-300.9M	598.82M	-629.34M	-646.18M	-202.11M	30.14M	-161.71M	-410.3M	-181.56M	40.76M
Dividends Paid	-119.26M	-182.09M	-325.22M	-335.44M	-278.3M	-262.92M	-277.16M	-277.45M	-280.15M	-289.5M
Common Dividends	-119.26M	-182.09M	-325.22M	-335.44M	-278.3M	-262.92M	-277.16M	-277.45M	-280.15M	0
Debt Issuance (Net)	-1000K	1000K	-1000K	-1000K	-1000K	1000K	1000K	-1000K	1000K	0
Share Repurchases	0	0	-143.75M	0	0	0	-4.81M	-2.68M	0	0
Other Financing	-5.94M	-15.75M	-2.54M	-10.82M	-830K	-39.51M	-2.52M	-36.04M	-94K	330.25M
Net Change in Cash+	18.23M	492.97M	-527.79M	-10.52M	16.38M	50.36M	-61.95M	-7.21M	19.62M	11.8M
Exchange Rate Effect	25K	738K	-539K	346K	88K	29K	268K	-614K	-359K	0
Cash at Beginning	7.43M	25.66M	587.45M	59.66M	49.14M	65.52M	115.89M	53.93M	46.72M	66.34M
Cash at End	25.66M	518.63M	59.66M	49.14M	65.52M	115.89M	53.93M	46.72M	66.34M	78.14M
Free Cash Flow+	176.74M	-200.64M	451.89M	372.48M	249.26M	322.78M	315.73M	300.57M	310.54M	348.61M
FCF Growth %	45.94%	-213.52%	325.22%	-17.57%	-33.08%	29.5%	-2.18%	-4.8%	3.32%	12.26%
FCF / Revenue %	-	-	-	-	-	-	-	-	-	-

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
FFO per Share	2.49	3.04	3.27	1.33	1.52	0.3	0.48	0.85	1.26	1.4
FFO Payout Ratio	73.06%	56.58%	55.57%	134.15%	88.31%	399.97%	251.56%	140.95%	94.54%	84.59%
NOI Margin	97.81%	95.6%	92.05%	83.58%	78.02%	75.21%	73.97%	69.85%	67.71%	100%
Net Debt / EBITDA	4.67x	7.42x	5.19x	3.43x	5.68x	5.98x	5.91x	5.94x	5.59x	3.48x
Debt / Assets	53.43%	48.27%	48.49%	40.89%	40.6%	40.96%	44.35%	45.42%	46.09%	22.88%
Interest Coverage	2.48x	2.54x	2.09x	4.17x	-	2.14x	2.23x	1.96x	2.23x	-
Book Value / Share	15.5	32.48	18.21	18.54	16.45	15.43	13.23	12.04	11.61	11.55
Revenue Growth	9.07%	55.7%	53.68%	7.18%	-10.42%	-4.85%	9.7%	3.63%	8.61%	10.15%

US Stock Screener

...

Sabra Health Care REIT, Inc. (SBRA) 10-Year Financial Performance & Capital Metrics

SBRA • • REIT / Real Estate

Real EstateHealthcare REITsSenior housing and skilled nursing

Revenue $775M +10.2%
FFO $342M +15.5%
FFO/Share 1.40 +11.5%
FFO Payout 84.59% -10.5%
FFO per Share 1.40 +11.5%
NOI Margin 100% +47.7%
FFO Margin 44.18% +4.8%
ROE 5.58% +22.1%
ROA 2.88% +21.3%
Debt/Assets 22.88% -50.3%
Net Debt/EBITDA 3.48 -37.7%
Book Value/Share 11.55 -0.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓FFO growing 15.4% TTM
✓High NOI margin of 100.0%
✓Healthy dividend yield of 5.8%
✓Trading near 52-week high

✗Weaknesses

✗Weak 3Y average ROE of 3.5%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y12.48%

5Y5.29%

3Y7.43%

TTM10.15%

Profit (Net Income) CAGR

10Y6.93%

5Y2.32%

3Y-

TTM22.21%

EPS CAGR

10Y-

5Y-

3Y-

TTM0.45%

ROCE

10Y Avg5.2%

5Y Avg4.25%

3Y Avg4.61%

Latest-

Peer Comparison

Senior housing and skilled nursing

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OHIOmega Healthcare Investors, Inc.	13.47B	48.27	31.14	10.7%	50.19%	10.98%	5.56%	1.02
NHINational Health Investors, Inc.	4.06B	84.07	27.84	12.07%	380.47%	92.81%	5.83%
CTRECareTrust REIT, Inc.	9.05B	40.62	25.87	108.71%	80.64%	6.51%	4.35%
STRWStrawberry Fields REIT LLC	167.94M	12.80	22.46	17.29%	4.83%	11.22%	21.04%	8.04
LTCLTC Properties, Inc.	1.92B	39.68	15.75	25.26%	44.88%	10.15%	7.07%	0.55
SBRASabra Health Care REIT, Inc.	5.17B	20.55		10.15%	19.99%	5.48%	6.74%	0.45

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue+	260.53M	405.65M	623.41M	668.18M	598.57M	569.54M	624.81M	647.51M	703.24M	774.63M
Revenue Growth %	9.07%	55.7%	53.68%	7.18%	-10.42%	-4.85%	9.7%	3.63%	8.61%	10.15%
Property Operating Expenses	5.7M	17.86M	49.55M	109.71M	131.55M	141.2M	162.61M	195.25M	227.09M	0
Net Operating Income (NOI)+	-	-	-	-	-	-	-	-	-	-
NOI Margin %	-	-	-	-	-	-	-	-	-	-
Operating Expenses+	93.93M	163.4M	266.91M	30.89M	467.02M	217.59M	227.36M	230.56M	219.12M	53.71M
G&A Expenses	19.92M	32.4M	36.46M	30.89M	32.76M	34.67M	39.57M	47.47M	50.07M	53.71M
EBITDA+	253.85M	387.82M	613.14M	708.63M	416.29M	389.74M	422.62M	404.8M	426.65M	340.42M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization+	92.96M	163.43M	306.19M	181.04M	176.74M	178.99M	187.78M	183.09M	169.62M	187M
D&A / Revenue %	-	-	-	-	-	-	-	-	-	-
Operating Income+	160.89M	224.39M	306.95M	527.59M	0	210.75M	234.84M	221.71M	257.03M	0
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense+	64.87M	88.44M	147.11M	126.61M	100.42M	98.63M	105.47M	112.96M	115.27M	0
Interest Coverage	2.48x	2.54x	2.09x	4.17x	-	2.14x	2.23x	1.96x	2.23x	-
Non-Operating Income	27.01M	-14.93M	-122.92M	181.55M	-239.55M	223.53M	205.73M	92.99M	14.04M	0
Pretax Income+	70.2M	159.02M	282.13M	72.42M	139.13M	-111.41M	-76.36M	15.76M	127.72M	153.42M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	75.48M	651K	3.01M	3.4M	710K	1.84M	1.24M	2M	1M	-1.84M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	70.28M	158.38M	279.08M	69M	138.42M	-113.26M	-77.61M	13.76M	126.71M	155.26M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-11.51%	125.37%	76.21%	-75.28%	100.62%	-181.82%	31.48%	117.73%	821.14%	22.53%
Funds From Operations (FFO)+	-	-	-	-	-	-	-	-	-	-
FFO Margin %	-	-	-	-	-	-	-	-	-	-
FFO Growth %	14.56%	97.15%	81.87%	-57.28%	26.04%	-79.14%	67.61%	78.66%	50.54%	15.5%
FFO per Share+	-	-	-	-	-	-	-	-	-	-
FFO Payout Ratio %	-	-	-	-	-	-	-	-	-	-
EPS (Diluted)+	0.92	1.40	1.56	0.37	0.67	-0.52	-0.34	0.06	0.54	0.00
EPS Growth %	-17.12%	52.17%	11.43%	-76.28%	81.08%	-177.61%	34.62%	117.38%	813.71%	-100%
EPS (Basic)	0.92	1.40	1.57	0.37	0.67	-0.52	-0.34	0.06	0.54	0.00
Diluted Shares Outstanding	65.52M	105.84M	178.72M	188.13M	207.25M	219.07M	230.95M	232.79M	236.05M	244.5M

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets+	2.27B	7.03B	6.67B	6.07B	5.99B	5.97B	5.75B	5.39B	5.3B	5.49B
Asset Growth %	-8.86%	210.35%	-5.22%	-8.94%	-1.38%	-0.32%	-3.67%	-6.29%	-1.53%	3.58%
Real Estate & Other Assets+	-2.34B	-7.08B	-6.67B	-110.81M	-82.8M	5.5B	5.32B	4.98B	4.9B	0
PP&E (Net)	2.01B	5.99B	5.85B	9.3M	0	0	0	0	0	0
Investment Securities	1000K	1000K	1000K	0	0	1000K	1000K	1000K	1000K	0
Total Current Assets+	255.98M	870.73M	340.54M	0	0	253.99M	201.84M	180.53M	198.09M	182.83M
Cash & Equivalents	25.66M	518.63M	50.23M	49.14M	65.52M	112M	49.31M	41.28M	60.47M	71.54M
Receivables	0	1000K	1000K	0	0	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	68.82M	9.43M	-49.14M	-65.52M	3.89M	4.62M	5.43M	5.87M	0
Intangible Assets	26.25M	167.12M	131.1M	0	0	54.06M	40.13M	30.9M	27.46M	65.32M
Total Liabilities	1.25B	3.6B	3.41B	2.58B	2.58B	2.59B	2.69B	2.58B	2.56B	2.67B
Total Debt+	1.21B	3.39B	3.23B	2.48B	2.43B	2.44B	2.55B	2.45B	2.44B	1.26B
Net Debt	1.19B	2.88B	3.18B	2.43B	2.36B	2.33B	2.5B	2.41B	2.38B	1.19B
Long-Term Debt	1.21B	3.39B	3.23B	2.4B	2.35B	2.39B	2.31B	2.32B	2.31B	0
Short-Term Borrowings	4.13M	0	3.42M	3.57M	18.42M	0	196.98M	94.43M	106.55M	1.26B
Capital Lease Obligations	0	98.02M	83.73M	79.75M	57.73M	49.71M	42.24M	32.53M	26.85M	0
Total Current Liabilities+	39.64M	102.52M	94.83M	0	0	142.99M	339.24M	231.41M	224.45M	1.26B
Accounts Payable	39.64M	102.52M	94.83M	0	0	0	0	0	0	0
Deferred Revenue	1.25B	3.6B	3.41B	0	0	0	0	0	0	0
Other Liabilities	-644.48M	0	-1.29B	-2.48B	-2.41B	0	0	0	0	1.41B
Total Equity+	1.02B	3.44B	3.25B	3.49B	3.41B	3.38B	3.06B	2.8B	2.74B	2.82B
Equity Growth %	-3.63%	238.44%	-5.31%	7.18%	-2.27%	-0.87%	-9.56%	-8.31%	-2.19%	3.01%
Shareholders Equity	1.02B	3.43B	3.25B	3.49B	3.41B	3.38B	3.06B	2.8B	2.74B	2.82B
Minority Interest	35K	4.44M	4.33M	0	0	0	0	0	0	1.95M
Common Stock	653K	1.78M	1.78M	2.05M	2.11M	2.3M	2.31M	2.31M	2.38M	2.52M
Additional Paid-in Capital	1.21B	3.64B	3.51B	4.07B	4.16B	4.48B	4.49B	4.49B	4.59B	0
Retained Earnings	-192.2M	-217.24M	-271.6M	-573.28M	-716.2M	-1.1B	-1.45B	-1.72B	-1.87B	0
Preferred Stock	58K	58K	0	0	0	0	0	0	0	0
Return on Assets (ROA)	2.96%	3.41%	4.07%	1.08%	2.3%	-1.9%	-1.32%	0.25%	2.37%	2.88%
Return on Equity (ROE)	6.79%	7.11%	8.34%	2.05%	4.01%	-3.34%	-2.41%	0.47%	4.57%	5.58%
Debt / Assets	53.43%	48.27%	48.49%	40.89%	40.6%	40.96%	44.35%	45.42%	46.09%	22.88%
Debt / Equity	1.19x	0.99x	0.99x	0.71x	0.71x	0.72x	0.83x	0.87x	0.89x	0.45x
Net Debt / EBITDA	4.67x	7.42x	5.19x	3.43x	5.68x	5.98x	5.91x	5.94x	5.59x	3.48x
Book Value per Share	15.50	32.48	18.21	18.54	16.45	15.43	13.23	12.04	11.61	11.55

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	176.74M	133.49M	358.54M	372.48M	354.85M	356.39M	315.73M	300.57M	310.54M	348.61M
Operating CF Growth %	45.94%	-24.47%	168.6%	3.89%	-4.73%	0.43%	-11.41%	-4.8%	3.32%	12.26%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	70.2M	158.37M	279.12M	69.02M	138.42M	-113.26M	-77.61M	13.76M	126.71M	155.51M
Depreciation & Amortization	68.47M	112.97M	199.08M	181.55M	176.74M	178.99M	187.78M	183.09M	169.62M	187M
Stock-Based Compensation	7.5M	8.36M	7.65M	9.82M	7.91M	7.91M	7.45M	7.92M	8.99M	11.36M
Other Non-Cash Items	-17.78M	-22.86M	-36.31M	-22.16M	1.61M	32.2M	217.8M	98.55M	27.77M	-5.25M
Working Capital Changes	6.31M	-90.31M	-18.5M	-23.51M	-2.74M	22.7M	-19.69M	-2.73M	-22.55M	0
Cash from Investing+	142.36M	-240.07M	-258.49M	262.84M	-136.45M	-336.2M	-216.25M	103.13M	-109M	-377.96M
Acquisitions (Net)	-7.35M	77.86M	-354.46M	0	-16.65M	-7.77M	-142.91M	-5.24M	0	0
Purchase of Investments	-7.35M	-2.75M	-5.31M	-89.65M	-20.07M	-9.06M	-8.02M	-11.02M	0	0
Sale of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0	0	0
Other Investing	157.06M	15.19M	1.06M	347.42M	2.44M	-287.05M	-70.69M	119.39M	-109M	-377.96M
Cash from Financing+	-300.9M	598.82M	-629.34M	-646.18M	-202.11M	30.14M	-161.71M	-410.3M	-181.56M	40.76M
Dividends Paid	-119.26M	-182.09M	-325.22M	-335.44M	-278.3M	-262.92M	-277.16M	-277.45M	-280.15M	-289.5M
Common Dividends	-119.26M	-182.09M	-325.22M	-335.44M	-278.3M	-262.92M	-277.16M	-277.45M	-280.15M	0
Debt Issuance (Net)	-1000K	1000K	-1000K	-1000K	-1000K	1000K	1000K	-1000K	1000K	0
Share Repurchases	0	0	-143.75M	0	0	0	-4.81M	-2.68M	0	0
Other Financing	-5.94M	-15.75M	-2.54M	-10.82M	-830K	-39.51M	-2.52M	-36.04M	-94K	330.25M
Net Change in Cash+	18.23M	492.97M	-527.79M	-10.52M	16.38M	50.36M	-61.95M	-7.21M	19.62M	11.8M
Exchange Rate Effect	25K	738K	-539K	346K	88K	29K	268K	-614K	-359K	0
Cash at Beginning	7.43M	25.66M	587.45M	59.66M	49.14M	65.52M	115.89M	53.93M	46.72M	66.34M
Cash at End	25.66M	518.63M	59.66M	49.14M	65.52M	115.89M	53.93M	46.72M	66.34M	78.14M
Free Cash Flow+	176.74M	-200.64M	451.89M	372.48M	249.26M	322.78M	315.73M	300.57M	310.54M	348.61M
FCF Growth %	45.94%	-213.52%	325.22%	-17.57%	-33.08%	29.5%	-2.18%	-4.8%	3.32%	12.26%
FCF / Revenue %	-	-	-	-	-	-	-	-	-	-

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
FFO per Share	2.49	3.04	3.27	1.33	1.52	0.3	0.48	0.85	1.26	1.4
FFO Payout Ratio	73.06%	56.58%	55.57%	134.15%	88.31%	399.97%	251.56%	140.95%	94.54%	84.59%
NOI Margin	97.81%	95.6%	92.05%	83.58%	78.02%	75.21%	73.97%	69.85%	67.71%	100%
Net Debt / EBITDA	4.67x	7.42x	5.19x	3.43x	5.68x	5.98x	5.91x	5.94x	5.59x	3.48x
Debt / Assets	53.43%	48.27%	48.49%	40.89%	40.6%	40.96%	44.35%	45.42%	46.09%	22.88%
Interest Coverage	2.48x	2.54x	2.09x	4.17x	-	2.14x	2.23x	1.96x	2.23x	-
Book Value / Share	15.5	32.48	18.21	18.54	16.45	15.43	13.23	12.04	11.61	11.55
Revenue Growth	9.07%	55.7%	53.68%	7.18%	-10.42%	-4.85%	9.7%	3.63%	8.61%	10.15%

Sabra Health Care REIT, Inc. (SBRA) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare SBRA vs Peers

vs OHI

vs CTRE

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Sabra Health Care REIT, Inc. (SBRA) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare SBRA vs Peers

vs OHI

vs CTRE

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios